MONDAY, Oct. 20, 2025 (HealthDay News) -- For patients with diabetes and early-stage pulmonary malignancies, administration of a sodium-glucose cotransporter 2
CHEST: SGLT2 Inhibitors May Slow Nodule Growth in Pulmonary Malignancies
 HealthDay2 hrs ago
 HealthDay2 hrs ago
9


 LiveNOW from FOX News
 LiveNOW from FOX News Las Vegas Sun
 Las Vegas Sun NPR
 NPR People Books
 People Books NBC4 Washington
 NBC4 Washington Reuters US Top
 Reuters US Top Associated Press US and World News Video
 Associated Press US and World News Video Deseret News
 Deseret News Healthcare Dive
 Healthcare Dive Tribune Chronicle Community
 Tribune Chronicle Community Roll Call
 Roll Call